{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T23:04:55Z","timestamp":1780959895952,"version":"3.54.1"},"reference-count":58,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"CAPES, FAPEMIG","award":["CBB-APQ-00819-12"],"award-info":[{"award-number":["CBB-APQ-00819-12"]}]},{"name":"CAPES, FAPEMIG","award":["CBB-APQ-01778-2014"],"award-info":[{"award-number":["CBB-APQ-01778-2014"]}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","award":["APQ-482976\/2012-8"],"award-info":[{"award-number":["APQ-482976\/2012-8"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","award":["APQ-488237\/2013-0"],"award-info":[{"award-number":["APQ-488237\/2013-0"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","award":["APQ-467640\/2014-9"],"award-info":[{"award-number":["APQ-467640\/2014-9"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parasitology International"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.parint.2018.10.005","type":"journal-article","created":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T16:58:54Z","timestamp":1539709134000},"page":"63-72","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["A Pluronic\u00ae F127-based polymeric micelle system containing an antileishmanial molecule is immunotherapeutic and effective in the treatment against Leishmania amazonensis infection"],"prefix":"10.1016","volume":"68","author":[{"given":"Grasiele S.V.","family":"Tavares","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00e9bora V.C.","family":"Mendon\u00e7a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina K.","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela P.","family":"Lage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tauane G.","family":"Soyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00edvia M.","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flaviano M.","family":"Ottoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel S.","family":"Dias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patr\u00edcia A.F.","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana M.R.","family":"Antinarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda","family":"Ludolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana C.","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine S.","family":"Coimbra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel A.","family":"Ch\u00e1vez-Fumagalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno M.","family":"Roatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Menezes-Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 M\u00e1rio","family":"Barichello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo J.","family":"Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo A.F.","family":"Coelho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.parint.2018.10.005_bb0005","author":"World Health Organization"},{"key":"10.1016\/j.parint.2018.10.005_bb0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035671","article-title":"Leishmaniasis worldwide and global estimates of its incidence","volume":"7","author":"Alvar","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.parint.2018.10.005_bb0015","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.det.2015.03.018","article-title":"New World and Old World Leishmania Infections: A Practical Review","volume":"33","author":"Kevric","year":"2015","journal-title":"Dermatol. Clin."},{"key":"10.1016\/j.parint.2018.10.005_bb0020","doi-asserted-by":"crossref","first-page":"536","DOI":"10.4269\/ajtmh.1991.44.536","article-title":"Leishmaniasis in Bahia, Brazil: evidence that Leishmania amazonensis produces a wide spectrum of clinical disease","volume":"44","author":"Barral","year":"1991","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.parint.2018.10.005_bb0025","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s00281-012-0350-8","article-title":"Immunopathogenesis of non-healing American cutaneous leishmaniasis and progressive visceral leishmaniasis","volume":"34","author":"Soong","year":"2012","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.parint.2018.10.005_bb0030","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1128\/CMR.6.3.230","article-title":"Leishmaniasis of the New World: current concepts and implications for future research","volume":"6","author":"Grimaldi","year":"1993","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.parint.2018.10.005_bb0035","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.mib.2012.05.002","article-title":"Making an anti-amastigote vaccine for visceral leishmaniasis: rational, update and perspectives","volume":"15","author":"Fernandes","year":"2012","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.parint.2018.10.005_bb0040","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1385\/IR:27:2-3:489","article-title":"Development and regulation of cell-mediated immunity in experimental leishmaniasis","volume":"27","author":"Scott","year":"2003","journal-title":"Immunol. Res."},{"key":"10.1016\/j.parint.2018.10.005_bb0045","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.cyto.2017.07.001","article-title":"D, M1 homeopathic complex trigger effective responses against Leishmania (L) amazonensis in vivo and in vitro","volume":"99","author":"Nascimento","year":"2017","journal-title":"Cytokine"},{"key":"10.1016\/j.parint.2018.10.005_bb0050","doi-asserted-by":"crossref","first-page":"8","DOI":"10.4103\/0972-9062.179209","article-title":"Laboratory diagnosis of human visceral leishmaniasis","volume":"53","author":"Sakkas","year":"2016","journal-title":"J. Vector Borne Dis."},{"key":"10.1016\/j.parint.2018.10.005_bb0055","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1128\/JCM.00372-14","article-title":"Molecular tools for diagnosis of visceral leishmaniasis: systematic review and meta-analysis of diagnostic test accuracy","volume":"52","author":"Ruiter","year":"2014","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.parint.2018.10.005_bb0060","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1586\/eri.10.19","article-title":"Current diagnosis and treatment of cutaneous and mucocutaneous leishmaniasis, Expert","volume":"8","author":"Goto","year":"2010","journal-title":"Rev. Anti Infect. Ther."},{"key":"10.1016\/j.parint.2018.10.005_bb0065","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/239469","article-title":"Developments in diagnosis of visceral leishmaniasis in the elimination era","volume":"2015","author":"Singh","year":"2015","journal-title":"J. Parasitol. Res."},{"key":"10.1016\/j.parint.2018.10.005_bb0070","doi-asserted-by":"crossref","first-page":"961","DOI":"10.3855\/jidc.4310","article-title":"Diagnosis of leishmaniasis","volume":"8","author":"Elmahallawy","year":"2014","journal-title":"J. Infect. Dev. Ctries."},{"key":"10.1016\/j.parint.2018.10.005_bb0075","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.actatropica.2015.09.003","article-title":"Microbiological laboratory diagnostics of neglected zoonotic diseases (NZDs)","volume":"165","author":"Schwarz","year":"2017","journal-title":"Acta Trop."},{"key":"10.1016\/j.parint.2018.10.005_bb0080","first-page":"128","article-title":"H, Application of recombinant proteins for serodiagnosis of visceral leishmaniasis in humans and dogs, Iran Biomed","author":"Farahmand","year":"2016","journal-title":"J. 20"},{"key":"10.1016\/j.parint.2018.10.005_bb0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002233","article-title":"Diagnosis of visceral leishmaniasis in Bihar India: comparison of the rK39 rapid diagnostic test on whole blood versus serum","volume":"7","author":"Matlashewski","year":"2013","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.parint.2018.10.005_bb0090","doi-asserted-by":"crossref","first-page":"76","DOI":"10.4269\/ajtmh.2006.74.76","article-title":"Evaluation of a new recombinant K39 rapid diagnostic test for Sudanese visceral leishmaniasis","volume":"74","author":"Ritmeijer","year":"2006","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.parint.2018.10.005_bb0095","first-page":"98","article-title":"Recent developments and future prospects in the treatment of visceral leishmaniasis","volume":"3","author":"Sundar","year":"2016","journal-title":"Ther. Adv. Infect. Dis."},{"key":"10.1016\/j.parint.2018.10.005_bb0100","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.ejmech.2018.08.012","article-title":"An update on small molecule strategies targeting leishmaniasis","volume":"157","author":"Kapil","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.parint.2018.10.005_bb0105","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1017\/S0031182017002116","article-title":"Chemotherapeutics of visceral leishmaniasis: present and future developments","volume":"145","author":"Sundar","year":"2018","journal-title":"Parasitology"},{"key":"10.1016\/j.parint.2018.10.005_bb0110","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1016\/j.drudis.2017.06.004","article-title":"Leishmaniasis drug discovery: recent progress and challenges in assay development","volume":"22","author":"Zulfiqar","year":"2017","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.parint.2018.10.005_bb0115","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.4269\/ajtmh.17-0094","article-title":"Efficacy and safety of liposomal amphotericin B for visceral Leishmaniasis in children and adolescents at a tertiary care Center in Bihar, India","volume":"97","author":"Pandey","year":"2017","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.parint.2018.10.005_bb0120","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.actatropica.2018.03.016","article-title":"Liposomal amphotericin B treatment of Old World cutaneous and mucosal leishmaniasis: a literature review","volume":"182","author":"Mosimann","year":"2018","journal-title":"Acta Trop."},{"key":"10.1016\/j.parint.2018.10.005_bb0125","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.amsu.2017.07.057","article-title":"Medicinal plants with promising antileishmanial activity in Iran: a systematic review and meta-analysis","volume":"21","author":"Soosaraei","year":"2017","journal-title":"Ann. Med. Surg. (Lond)."},{"key":"10.1016\/j.parint.2018.10.005_bb0130","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.exppara.2018.02.003","article-title":"Comparing the therapeutic efficacy of different amphotericin B-carrying delivery systems against visceral leishmaniasis","volume":"186","author":"Mendon\u00e7a","year":"2018","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.parint.2018.10.005_bb0135","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.ejmech.2013.07.057","article-title":"Synthesis of quinoidal molecules: strategies towards bioactive compounds with an emphasis on lapachones","volume":"69","author":"Castro","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.parint.2018.10.005_bb0140","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1016\/j.nano.2015.07.011","article-title":"Assessment of \u03b2-lapachone loaded in lecithin-chitosan nanoparticles for the topical treatment of cutaneous leishmaniasis in L. major infected BALB\/c mice","volume":"11","author":"Moreno","year":"2015","journal-title":"Nanomedicine"},{"key":"10.1016\/j.parint.2018.10.005_bb0145","doi-asserted-by":"crossref","first-page":"E70","DOI":"10.3390\/molecules23010070","article-title":"Hydrazone derivatives enhance antileishmanial activity of thiochroman-4-ones","volume":"23","author":"Vargas","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.parint.2018.10.005_bb0150","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12929-018-0408-6","article-title":"Discovery and cellular stress pathway analysis of 1,4-naphthoquinone derivatives with novel, highly potent broad-spectrum anticancer activity","volume":"25","author":"Ghosh","year":"2018","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.parint.2018.10.005_bb0155","doi-asserted-by":"crossref","first-page":"4107","DOI":"10.2147\/IJN.S163929","article-title":"Nanostructured lipid carriers co-delivering lapachone and doxorubicin for overcoming multidrug resistance in breast cancer therapy","volume":"13","author":"Li","year":"2018","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.parint.2018.10.005_bb0160","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/bcpt.12990","article-title":"Antileishmanial activity, Cytotoxicity and Mechanism of Action of Clioquinol against Leishmania infantum and Leishmania amazonensis Species","volume":"123","author":"Tavares","year":"2018","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.parint.2018.10.005_bb0165","doi-asserted-by":"crossref","first-page":"3988","DOI":"10.1128\/IAI.71.7.3988-3994.2003","article-title":"Immune responses induced by the Leishmania (Leishmania) donovani A2 antigen, but not by the LACK antigen, are protective against experimental Leishmania (Leishmania) amazonensis infection","volume":"71","author":"Coelho","year":"2003","journal-title":"Infect. Immun."},{"key":"10.1016\/j.parint.2018.10.005_bb0170","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.parint.2016.07.005","article-title":"Treatment of murine visceral leishmaniasis using an 8-hydroxyquinoline-containing polymeric micelle system","volume":"65","author":"Duarte","year":"2016","journal-title":"Parasitol. Int."},{"key":"10.1016\/j.parint.2018.10.005_bb0175","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cellimm.2017.11.001","article-title":"Recombinant prohibitin protein of Leishmania infantum acts as a vaccine candidate and diagnostic marker against visceral leishmaniasis","volume":"323","author":"Dias","year":"2018","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.parint.2018.10.005_bb0180","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1517\/13543776.2014.993969","article-title":"New perspectives for leishmaniasis chemotherapy over current anti-leishmanial drugs: a patent landscape","volume":"25","author":"Machado-Silva","year":"2015","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.parint.2018.10.005_bb0185","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1166\/jbn.2017.2349","article-title":"Nanotechnological strategies for Treatment of Leishmaniasis--a Review","volume":"13","author":"Almeida","year":"2017","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.parint.2018.10.005_bb0190","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1086\/507530","article-title":"Liposomal amphotericin B for the treatment of visceral leishmaniasis","volume":"43","author":"Bern","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.parint.2018.10.005_bb0195","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1590\/0037-8682-0455-2016","article-title":"Efficacy and safety of amphotericin B deoxycholate versus N-methylglucamine antimoniate in pediatric visceral leishmaniasis: an open-label, randomized, and controlled pilot trial in Brazil","volume":"50","author":"Borges","year":"2017","journal-title":"Rev. Soc. Bras. Med.Trop."},{"key":"10.1016\/j.parint.2018.10.005_bb0200","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1097\/QCO.0b013e328359eff2","article-title":"Recent advances in development of amphotericin B formulations for the treatment of visceral leishmaniasis","volume":"25","author":"Mohamed-Ahmed","year":"2012","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.parint.2018.10.005_bb0205","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.ijbiomac.2017.07.161","article-title":"Chitosan coated PluronicF127 micelles for effective delivery of Amphotericin B in experimental visceral leishmaniasis","volume":"105","author":"Singh","year":"2017","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.parint.2018.10.005_bb0210","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ijpddr.2018.04.001","article-title":"Comparative efficacy, toxicity and biodistribution of the liposomal amphotericin B formulations Fungisome\u00ae and AmBisome\u00ae in murine cutaneous leishmaniasis","volume":"8","author":"Wijnant","year":"2018","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"10.1016\/j.parint.2018.10.005_bb0215","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1517\/17425247.2012.701204","article-title":"Drug delivery systems for the topical treatment of cutaneous leishmaniasis","volume":"9","author":"Carneiro","year":"2012","journal-title":"Expert. Opin. Drug. Deliv."},{"key":"10.1016\/j.parint.2018.10.005_bb0220","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1590\/0037-8682-0138-2015","article-title":"New delivery systems for amphotericin B applied to the improvement of leishmaniasis treatment","volume":"48","author":"Ch\u00e1vez-Fumagalli","year":"2015","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"10.1016\/j.parint.2018.10.005_bb0225","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1080\/10611860500046732","article-title":"Targeted delivery of arjunglucoside I using surface hydrophilic and hydrophobic nanocarriers to combat experimental leishmaniasis","volume":"13","author":"Tyagi","year":"2005","journal-title":"J. Drug Target."},{"key":"10.1016\/j.parint.2018.10.005_bb0230","doi-asserted-by":"crossref","first-page":"4083","DOI":"10.1007\/s00436-016-5181-4","article-title":"An 8-hydroxyquinoline-containing polymeric micelle system is effective for the treatment of murine tegumentary leishmaniasis","volume":"115","author":"Lage","year":"2016","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.parint.2018.10.005_bb0235","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1016\/S0142-9612(01)00050-3","article-title":"Amphiphilic poly-N-vinylpyrrolidones: synthesis, properties and liposome surface modification","volume":"22","author":"Torchilin","year":"2001","journal-title":"Biomaterials"},{"key":"10.1016\/j.parint.2018.10.005_bb0240","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.exppara.2018.07.003","article-title":"Bovine serum albumin nanoparticles containing amphotericin B were effective in treating murine cutaneous leishmaniasis and reduced the drug toxicity","volume":"192","author":"Casa","year":"2018","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.parint.2018.10.005_bb0245","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0077560","article-title":"Synthetic oxoisoaporphine alkaloids: in vitro, in vivo and in silico assessment of antileishmanial activities","volume":"8","author":"Sobarzo-S\u00e1nchez","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.parint.2018.10.005_bb0250","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1186\/s13071-017-2509-6","article-title":"Germacranolide-type sesquiterpene lactones from Smallanthus sonchifolius with promising activity against Leishmania mexicana and Trypanosoma cruzi","volume":"10","author":"Ulloa","year":"2017","journal-title":"Parasit. Vectors"},{"key":"10.1016\/j.parint.2018.10.005_bb0255","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ijantimicag.2017.06.010","article-title":"The chemotherapeutic potential of chalcones against leishmaniases: a review","volume":"51","author":"Tajuddeen","year":"2018","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.parint.2018.10.005_bb0260","first-page":"5341","article-title":"An optimized nanoparticle delivery system based on chitosan and chondroitin sulfate molecules reduces the toxicity of amphotericin B and is effective in treating tegumentary leishmaniasis","volume":"9","author":"Ribeiro","year":"2014","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.parint.2018.10.005_bb0265","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ejps.2015.01.015","article-title":"Nanoemulsions loaded with amphotericin B: a new approach for the treatment of leishmaniasis","volume":"70","author":"Caldeira","year":"2015","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.parint.2018.10.005_bb0270","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1039\/C6TX00253F","article-title":"Metabolomics as a tool to evaluate the toxicity of formulations containing amphotericin B, an antileishmanial drug","volume":"5","author":"Santos","year":"2016","journal-title":"Toxicol. Res. (Camb)."},{"key":"10.1016\/j.parint.2018.10.005_bb0275","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/cbdd.12540","article-title":"4-aminoquinoline derivatives as potential antileishmanial agents","volume":"86","author":"Antinarelli","year":"2015","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.parint.2018.10.005_bb0280","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1007\/s11095-011-0586-3","article-title":"Mitochondria and trypanosomatids: targets and drugs","volume":"28","author":"Fidalgo","year":"2011","journal-title":"Pharm. Res."},{"key":"10.1016\/j.parint.2018.10.005_bb0285","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/j.1747-0285.2010.00962.x","article-title":"Synthesis, cytotoxicity and antileishmanial activity of some N-(2-(indol-3-yl)ethyl)-7-chloroquinolin-4-amines","volume":"75","author":"Coimbra","year":"2010","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.parint.2018.10.005_bb0290","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/bcpt.12990","article-title":"Antileishmanial activity, cytotoxicity and mechanism of action of clioquinol against Leishmania infantum and Leishmania amazonensis species","volume":"123","author":"Tavares","year":"2018","journal-title":"Basic Clin. Pharmacol. Toxicol."}],"container-title":["Parasitology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1383576918303751?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1383576918303751?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T12:20:53Z","timestamp":1720700453000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1383576918303751"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S1383576918303751"],"URL":"https:\/\/doi.org\/10.1016\/j.parint.2018.10.005","relation":{},"ISSN":["1383-5769"],"issn-type":[{"value":"1383-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Pluronic\u00ae F127-based polymeric micelle system containing an antileishmanial molecule is immunotherapeutic and effective in the treatment against Leishmania amazonensis infection","name":"articletitle","label":"Article Title"},{"value":"Parasitology International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parint.2018.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}